People May Be Exposed To NDMA From Many Sources

Zantac, found to contain dangerously high levels of NDMA, is off the market, but people are exposed to dangerous accumulations of the chemical compound in many other ways

Tuesday, January 19, 2021 - For more than the last year, researchers in the government and private sector have struggled to pinpoint why NDMA increases carcinogenic levels in Zantac and other heartburn medicines and some diabetes medications. Scientists now believe that there are several different ways each contribute to elevated levels of NDMA, a carcinogen, being present in ranitidine (Zantac) and metformin tablets. Ranitidine is a fundamentally unstable chemical that degenerates into NDMA when stored at above-average temperatures. Ranitidine also breaks down when it interacts with nitrates in the stomach. Zantac stomach cancer lawyers are helping Americans nationwide by offering a free consultation before filing a lawsuit claim.

The Minnesota Department of Health found elevated levels of NDMA "in many processed foods and beverages such as whiskey, beer, cured meats, bacon, and cheeses." NDMA may be safe when ingested in small and infrequent amounts. The FDA has set a limit of 96 NGs per Zantac tablet. Zantac's cancer problem may be because Zantac is recommended by doctors to be taken daily as long as the patient experiences heartburn, exposing the patient to potentially harmful accumulations of NDMA over many years. Sanofi, the maker of Zantac, faces more than 500 lawsuits and possibly many more to come over its role in concealing what they knew about the instability of ranitidine.

Exposure to NDMA can occur in many other places also. The Minnesota Department of Health lists potential sources of NDMA that should be avoided or limited. "Most NDMA exposure occurs when you eat foods that contain nitrosamines, such as smoked or cured meats, bacon, some fish, canned fruit, soybean oil, and cheeses; or when you drink malt beverages, such as beer and whiskey. You can be exposed to NDMA when you use toiletry and cosmetic products such as shampoos and cleansers that contain NDMA. Breathing in cigarette smoke will also expose you to NDMA. Workplace exposure can occur at tanneries, pesticide manufacturing plants, and rubber and tire plants." Ranitidine is also suspected to become contaminated with NDMA from the environment where it is manufactured in China and India. The US Food and Drug Administration is looking into the causes of NDMA contamination, and also the Department of Justice is investigating Sanofi to see if they lied to government regulators about their knowledge of NDMA being accelerated in Zantac. Zantac cancer cases are being organized in multidistrict litigation and the first bellwether cases could be heard in 2022.

Zantac was the leading heartburn and acid reflux medicine in the world until Sanofi voluntarily pulled the medicine from the market over elevated NDMA cancer concerns. The FDA followed and recalled all ranitidine heartburn medicines on April 1, 2020. If you or a loved one have developed cancer of the stomach, bladder, esophagus, or other cancer, and have used Zantac regularly for many years, you should speak with a Zantac Cancer Lawyers to discuss filing a claim for lump-sum monetary damages.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.